受强制性开放获取政策约束的文章 - Andrii Monastyrskyi了解详情
无法在其他位置公开访问的文章：3 篇
Transition-metal-free one-pot tandem synthesis of 4-quinolone and 4H-thiochromen-4-one derivatives through sequential nucleophilic addition–elimination–SNAr reaction
D Wang, P Sun, P Jia, J Peng, Y Yue, C Chen
Synthesis 49 (18), 4309-4320, 2017
强制性开放获取政策： 国家自然科学基金委员会
Potassium tert-butoxide mediated arylation of 2-substituted malononitriles using diaryliodonium salts
J Han, X Qian, B Xu, L Wang
Synlett 28 (16), 2139-2142, 2017
强制性开放获取政策： 国家自然科学基金委员会
Scalable Multigram Syntheses of Antimalarial 4 (1H)‐Quinolones ELQ‐300 and P4Q‐391
NK Namelikonda, A Monastyrskyi, R Manetsch
European Journal of Organic Chemistry 2017 (23), 3328-3334, 2017
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：16 篇
The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells
K Maharaj, JJ Powers, A Achille, M Mediavilla-Varela, W Gamal, ...
Blood advances 4 (13), 3072-3084, 2020
强制性开放获取政策： US National Institutes of Health
Metal-Free Arylation of Ethyl Acetoacetate with Hypervalent Diaryliodonium Salts: An Immediate Access to Diverse 3-Aryl-4(1H)-Quinolones
A Monastyrskyi, NK Namelikonda, R Manetsch
The Journal of organic chemistry 80 (5), 2513-2520, 2015
强制性开放获取政策： US National Institutes of Health
Orally Bioavailable 6-Chloro-7-methoxy-4(1H)-quinolones Efficacious against Multiple Stages of Plasmodium
RM Cross, DL Flanigan, A Monastyrskyi, AN LaCrue, FE Sáenz, ...
Journal of Medicinal Chemistry 57 (21), 8860-8879, 2014
强制性开放获取政策： US National Institutes of Health
4(1H)-Quinolones with Liver Stage Activity against Plasmodium berghei
AN LaCrue, FE Sáenz, RM Cross, KO Udenze, A Monastyrskyi, S Stein, ...
Antimicrobial agents and chemotherapy 57 (1), 417-424, 2013
强制性开放获取政策： US National Institutes of Health
Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure–Activity and Structure–Property …
R Neelarapu, JR Maignan, CL Lichorowic, A Monastyrskyi, TS Mutka, ...
Journal of medicinal chemistry 61 (4), 1450-1473, 2018
强制性开放获取政策： US National Institutes of Health
Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer
A Monastyrskyi, N Nilchan, V Quereda, Y Noguchi, C Ruiz, W Grant, ...
Bioorganic & medicinal chemistry 26 (3), 590-602, 2018
强制性开放获取政策： US National Institutes of Health
4 (1H)-pyridone and 4 (1H)-quinolone derivatives as antimalarials with erythrocytic, exoerythrocytic, and transmission blocking activities
A Monastyrskyi, D E Kyle, R Manetsch
Current topics in medicinal chemistry 14 (14), 1693-1705, 2014
强制性开放获取政策： US National Institutes of Health
Aminoalkoxycarbonyloxymethyl ether prodrugs with a pH-triggered release mechanism: A case study improving the solubility, bioavailability, and efficacy of antimalarial 4 (1 H …
A Monastyrskyi, F Brockmeyer, AN LaCrue, Y Zhao, SP Maher, ...
Journal of medicinal chemistry 64 (10), 6581-6595, 2021
强制性开放获取政策： US National Institutes of Health
Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors
A Monastyrskyi, S Bayle, V Quereda, W Grant, M Cameron, D Duckett, ...
Bioorganic & medicinal chemistry letters 28 (3), 400-404, 2018
强制性开放获取政策： US National Institutes of Health
Targeting casein kinase 1 delta sensitizes pancreatic and bladder cancer cells to gemcitabine treatment by upregulating deoxycytidine kinase
F Vena, S Bayle, A Nieto, V Quereda, M Aceti, SM Frydman, SS Sansil, ...
Molecular cancer therapeutics 19 (8), 1623-1635, 2020
强制性开放获取政策： US National Institutes of Health
Chemical proteomics with novel fully functionalized fragments and stringent target prioritization identifies the glutathione-dependent isomerase GSTZ1 as a lung cancer target
Y Liao, S Chin Chan, EA Welsh, B Fang, L Sun, E Schönbrunn, ...
ACS Chemical Biology 18 (2), 251-264, 2023
强制性开放获取政策： US National Institutes of Health
Going beyond binary: rapid identification of protein–protein interaction modulators using a multifragment kinetic target-guided synthesis approach
K Nacheva, SS Kulkarni, M Kassu, D Flanigan, A Monastyrskyi, ID Iyamu, ...
Journal of Medicinal Chemistry 66 (7), 5196-5207, 2023
强制性开放获取政策： US National Institutes of Health
The reversible inhibitor SR-4835 binds Cdk12/cyclin K in a noncanonical G-loop conformation
M Schmitz, IH Kaltheuner, K Anand, R Düster, J Moecking, A Monastyrskyi, ...
Journal of Biological Chemistry 300 (1), 2024
强制性开放获取政策： US National Institutes of Health, German Research Foundation
CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma
KL Burger, MR Fernandez, MB Meads, P Sudalagunta, PS Oliveira, ...
Cancer Research 83 (23), 3901-3919, 2023
强制性开放获取政策： US National Institutes of Health
Enantio‐ and Diastereoselective (Ipc)2BOTf‐Mediated Aldol Reactions of Morpholine Carboxamides
L Pedzisa, A Monastyrskyi, CD Parker, WR Roush
Helvetica Chimica Acta 106 (12), e202300126, 2023
强制性开放获取政策： US National Institutes of Health
Chemical Biology
P Ghosh, M Schmitz, T Pandurangan, ST Zeleke, SC Chan, J Mosior, ...
强制性开放获取政策： US Department of Defense, US National Institutes of Health
出版信息和资助信息由计算机程序自动确定